Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel P Haas

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
European Urology|August 31, 2014
Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trialFred Saad, Johann de Bono, Neal Shore, et al.
Vaccine|August 17, 2010
IRX-2 increases the T cell-specific immune response to protein/peptide vaccinesPaul H Naylor, Karla E Hernandez, April E Nixon, et al.
Anticancer Research|February 6, 2009
Autopsy evaluation of a prostate cancer case treated with brachytherapyAnna Shapiro, Oleg Shapiro, Nicolas B Delongchamps, et al.
The Journal of Urology|July 21, 2009
Pathological characteristics of prostate cancer in elderly menNicolas B Delongchamps, Ching Y Wang, Vishal Chandan, et al.
Plos One|July 7, 2015
Association of MnSOD AA Genotype with the Progression of Prostate CancerTaro Iguchi, Ching Y Wang, Nicolas B Delongchamps, et al.
Cell Reports. Medicine|August 21, 2024
HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHESNima Sharifi, Arun A Azad, Mona Patel, et al.
Prostate Cancer and Prostatic Diseases|March 27, 2025
Enzalutamide in patients with high-risk biochemically recurrent prostate cancer according to the European Association of Urology definition: a post hoc analysis of EMBARKUgo De Giorgi, Stephen J Freedland, Antti Rannikko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2026
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With EnzalutamideAndrew J Armstrong, Arun A Azad, Taro Iguchi, et al.
The Journal of Urology|October 5, 2014
A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomyFernando J Bianco, David M Albala, Laurence H Belkoff, et al.
Journal of the National Cancer Institute|September 27, 2007
Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalenceGabriel P Haas, Nicolas Barry Delongchamps, Richard F Jones, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
European Urology|August 31, 2014
Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trialFred Saad, Johann de Bono, Neal Shore, et al.
Vaccine|August 17, 2010
IRX-2 increases the T cell-specific immune response to protein/peptide vaccinesPaul H Naylor, Karla E Hernandez, April E Nixon, et al.
Anticancer Research|February 6, 2009
Autopsy evaluation of a prostate cancer case treated with brachytherapyAnna Shapiro, Oleg Shapiro, Nicolas B Delongchamps, et al.
The Journal of Urology|July 21, 2009
Pathological characteristics of prostate cancer in elderly menNicolas B Delongchamps, Ching Y Wang, Vishal Chandan, et al.
Plos One|July 7, 2015
Association of MnSOD AA Genotype with the Progression of Prostate CancerTaro Iguchi, Ching Y Wang, Nicolas B Delongchamps, et al.
Cell Reports. Medicine|August 21, 2024
HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHESNima Sharifi, Arun A Azad, Mona Patel, et al.
Prostate Cancer and Prostatic Diseases|March 27, 2025
Enzalutamide in patients with high-risk biochemically recurrent prostate cancer according to the European Association of Urology definition: a post hoc analysis of EMBARKUgo De Giorgi, Stephen J Freedland, Antti Rannikko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2026
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With EnzalutamideAndrew J Armstrong, Arun A Azad, Taro Iguchi, et al.
The Journal of Urology|October 5, 2014
A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomyFernando J Bianco, David M Albala, Laurence H Belkoff, et al.
Journal of the National Cancer Institute|September 27, 2007
Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalenceGabriel P Haas, Nicolas Barry Delongchamps, Richard F Jones, et al.
Pageof 9